MLICM
EOLS icon

Metropolitan Life Insurance Company (MetLife)’s Evolus EOLS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,418
Closed -$33.9K – 677
2024
Q1 		$33.9K Hold
2,418
– – ﹤0.01% 1594
2023
Q4 		$25.5K Hold
2,418
– – ﹤0.01% 1804
2023
Q3 		$22.1K Buy
2,418
+461
+24% +$4.13K ﹤0.01% 1844
2023
Q2 		$14.2K Buy
1,957
+755
+63% +$6.51K ﹤0.01% 2110
2023
Q1 		$10.2K Sell
1,202
-1,096
-48% -$9.91K ﹤0.01% 2155
2022
Q4 		$17.3K Hold
2,298
– – ﹤0.01% 2090
2022
Q3 		$18.5K Hold
2,298
– – ﹤0.01% 2064
2022
Q2 		$26.7K Hold
2,298
– – ﹤0.01% 1893
2022
Q1 		$25.8K Buy
+2,298
New +$19.6K ﹤0.01% 1970
2021
Q4 		– Sell
-4,123
Closed -$31.4K – 2799
2021
Q3 		$31.4K Sell
4,123
-5,785
-58% -$59.8K ﹤0.01% 2801
2021
Q2 		$125K Buy
+9,908
New +$109K ﹤0.01% 2475
2019
Q4 		– Sell
-5,736
Closed -$89.6K – 2545
2019
Q3 		$89.6K Buy
5,736
+2,042
+55% +$33.5K ﹤0.01% 2361
2019
Q2 		$54K Hold
3,694
– – ﹤0.01% 2496
2019
Q1 		$83.4K Buy
+3,694
New +$79.9K ﹤0.01% 2417

Other funds holding EOLS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s EOLS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Evolus (EOLS) in Q2 2024, closing a stake of 2,418 shares — an estimated $33.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EOLS in Q1 2019 and held it in 14 quarters. The position peaked at $125K in Q2 2021. 156 funds tracked by Wall St. Rank hold EOLS as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Evolus position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,418 Evolus shares in Q2 2024, an estimated $33.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Evolus in Q1 2019 and held it in 14 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Evolus position peaked at $125K in Q2 2021.
  • 156 funds tracked by Wall St. Rank held Evolus as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.